| Metric | Value ($ M) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 251.94 | 5.1% | 15.5% |
| Total Income | 251.94 | 5.1% | 15.5% |
| Expenditure | 281.02 | 24.1% | 23.1% |
| PBT | — | ||
| Net Profit | -29.46 | 377.4% | 158.9% |
| OPM | -11.54% | 17.07pp | 6.88pp |
| NPM | -11.69% | 16.12pp | 6.48pp |
| EPS | -0.22 | 375.0% | 175.0% |
InnovAge Announces Q3 FY26 Financial Results
06 May 2026 · 6 May, 1:45 am
Summary
InnovAge Holding Corp. announced its financial results for the fiscal third quarter ended March 31, 2026. Total revenues increased by approximately 15.5% to $251.9 million compared to the same period last year. The company reported a Loss Before Income Taxes of $29.8 million. Adjusted EBITDA increased to $30.5 million, with the Adjusted EBITDA margin improving to 12.1%. Based on the year-to-date performance, InnovAge is raising its fiscal 2026 revenue and Adjusted EBITDA guidance.
Key Highlights
- 1
Total revenues for the third quarter of fiscal year 2026 were $251.9 million, an increase of approximately 15.5% compared to $218.1 million in the third quarter of fiscal year 2025.
- 2
The company's Loss Before Income Taxes was $29.8 million, a decrease of approximately 169.2% compared to a Loss Before Income Taxes of $11.1 million in the third quarter of fiscal year 2025.
- 3
Center-level Contribution Margin was $61.0 million, an increase of 49.8% compared to $40.7 million in the third quarter of fiscal year 2025.
- 4
Adjusted EBITDA was $30.5 million, an increase of $19.7 million compared to Adjusted EBITDA of $10.8 million in the third quarter of fiscal year 2025.
- 5
Adjusted EBITDA margin was 12.1%, an increase of 7.2 percentage points compared to 4.9% in the third quarter of fiscal year 2025.
- 6
The company ended the third quarter of fiscal year 2026 with $95.5 million in cash and cash equivalents plus $43.1 million in short-term investments.
Management Comments
Patrick Blair
We delivered a solid third quarter, reflecting continued improvement in operating execution and financial performance. These results are being driven by stronger performance across our centers and the benefits of the investments we’ve made over the past several years to strengthen our platform. At the same time, we continue reinvesting in our clinical teams, technology, and quality capabilities to further improve participant outcomes and experience over the long term. Based on our performance year to date, we are raising our fiscal 2026 revenue and Adjusted EBITDA guidance.
Informational and educational content only. Not investment advice.